Title |
Time Trends and Determinants of Pharmaceutical Expenditure in China (1990–2009)
|
---|---|
Published in |
PharmacoEconomics, July 2013
|
DOI | 10.1007/s40273-013-0072-3 |
Pubmed ID | |
Authors |
Lizheng Shi, Heidi Y. Yang, Gang Cheng, Qingyue Meng |
Abstract |
Pharmaceutical policy reform is currently one of the primary areas of health reform in China. The national pharmaceutical policy of China has multiple objectives: to develop the domestic pharmaceutical industry and encourage innovation, to control escalation of total pharmaceutical expenditures (TPE) which constitute a substantial component of total health expenditures (THE), and to ensure access to essential medicines for poor and uninsured patients. The current pharmaceutical system has been criticized for its high costs, questionable prescribing practices, and poor regulation of drug quality. This study aims to examine the time trends and influential factors of TPE in China. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Tanzania, United Republic of | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 73 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 18 | 24% |
Other | 10 | 13% |
Student > Ph. D. Student | 9 | 12% |
Researcher | 8 | 11% |
Student > Doctoral Student | 6 | 8% |
Other | 18 | 24% |
Unknown | 7 | 9% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 24 | 32% |
Social Sciences | 10 | 13% |
Economics, Econometrics and Finance | 8 | 11% |
Nursing and Health Professions | 7 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
Other | 13 | 17% |
Unknown | 9 | 12% |